Aberrant expression of homeobox transcription factor HOXA9 is a central component of the leukemogenic program driven by diverse oncogenes. Here we show that HOXA9 overexpression in myeloid progenitor
The hairy cell leukemia market was valued at USD 130.7 million in 2023 and is projected to grow at a CAGR of 6.5% between 2024 and 2032 owing to increasing prevalence of leukemia.
